A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 160
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : SLICC
Long Form : Systemic Lupus International Collaborating Clinics
No. Year Title Co-occurring Abbreviation
2020 Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective. ACR, EULAR, SLE
2020 Association of systemic lupus erythematosus disease activity index score with clinical and laboratory parameters in pediatric onset systemic lupus erythematosus. p-SLE, SLEDAI
2020 Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. ACR, BILAG, JSLE, SLE
2020 Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus. ACR, CB-CAPs, MAP, SLE, SS
2020 Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus. FI, SLE
2020 Different patterns of cerebral perfusion in SLE patients with and without neuropsychiatric manifestations. ASL, CBF, NCs, ROC, SLE, SLEDAI, SVM, VBA, WM
2020 Four Cases of Lupus Psychosis: Comment on the Article by Hanly et al. ---
2020 Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus. CSF, Gal-9, IFN, IQR, NPSLE, SLE
2020 In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment. ACR, EULAR, SLE
10  2020 Incomplete Systemic Lupus Erythematosus: What Remains After Application of American College of Rheumatology and Systemic Lupus International Collaborating Clinics criteria? iSLE
11  2020 Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease. ACR, ANA, HEp-2, IF, Ig, SLE, Sm
12  2020 Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study. ACR, GEE, GLM, HM, SLE
13  2020 Performance of the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus in Asian patients: a single-centre retrospective cohort study in Korea. APS, CI, EULAR/ACR, RA, SLE, SS
14  2020 Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index. FI, IRR, SDI, SLE
15  2020 Reply. ACA, SLE
16  2020 Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus. SDI, SLE, suPAR
17  2020 Stand-alone renal SLICC criterion with full house glomerular deposits: is it enough for childhood lupus nephritis? ANA, cSLE, dsDNA
18  2020 The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus. CS, dsDNA, HCQ, SLE, SLEDAI, SOC
19  2020 Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression. BC4d, CTD, E-C4d, SDI
20  2020 Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial. BILAG, SFI, SLE
21  2019 Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus. BAFF, HC, sBAFF-R, sBCMA, SDI, SLE
22  2019 Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria. ACR, SLE
23  2019 Comparison among ACR1997, SLICC and the new EULAR/ACR classification criteria in childhood-onset systemic lupus erythematosus. ACR, cSLE, EULAR
24  2019 Comparison of Sensitivities of American College of Rheumatology and Systemic Lupus International Collaborating Clinics Classification Criteria in Childhood-onset Systemic Lupus Erythematosus. ACR, cSLE, SLE
25  2019 Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus. ACR, ANAs, CLE, SLE
26  2019 Development of the Asia Pacific Lupus Collaboration cohort. ACR, APLC, LLDAS, SLE
27  2019 Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus. CV, SCORE, SLE, US
28  2019 Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach. ACR, SLE
29  2019 EULAR/ACR classification criteria for SLE. ACR, ANA, EULAR, SLE
30  2019 Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus. FI, SDI, SF-36, SLE
31  2019 Expression of vitamin D receptor in renal tissue of lupus nephritis and its association with renal injury activity. LN, SLE, VDR
32  2019 Lack of patient education is risk factor of disease flare in patients with systemic lupus erythematosus in China. BMQ, CQR, SIMS, SLE
33  2019 Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort. ACR, OPN, SDI, SLE
34  2019 Predisposing factors to nonfatal cardiovascular events in women with systemic lupus erythematosus. An observational, cross-sectional, multicenter study in Spain from the risk/systemic lupus erythematosus thematic network. CI, CVEs, HT, OR, SLE
35  2019 Self-reported disease severity in women with systemic lupus erythematosus. ACR, SLAM, SLE
36  2019 Systemic lupus erythematosus: genetic variants in Xq28 region. IRAK1, MECP2, OR, SLE, SLICC DI, SNPs
37  2019 The diagnostic accuracies of the 2012 SLICC criteria and the proposed EULAR/ACR criteria for systemic lupus erythematosus classification are comparable. ACR, CI, EULAR, SLE
38  2019 The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts. SLE, SS
39  2019 The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus. CSI, MMSE, MoCA, SLE
40  2019 Validation of the new classification criteria for systemic lupus erythematosus on a patient cohort from a national referral center: a retrospective study. ACR, ROC, SLE
41  2019 Vitamin D receptor expression in peripheral blood mononuclear cells is inversely associated with disease activity and inflammation in lupus patients. PBMCs, SLE, SLEDAI, VDR
42  2018 An Interesting Case of Neurobrucellosis Mimicking Neuropsychiatric Lupus. NPSLE
43  2018 Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients. PAPS, SLE
44  2018 Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC). SLE
45  2018 Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus. ACR, HRQoL, SLE, SLEDAI
46  2018 Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus. ACR, SLE, SLEDAI
47  2018 Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study. ACR, NPSLE, SLEDAI
48  2018 Salivary biomarkers of inflammation in systemic lupus erythematosus. IL-6, MCP-1, PAI-1, SLE
49  2018 Serum Midkine Levels in Systemic Lupus Erythematosus. MEX-SLEDAI, MK
50  2018 SLICC classification criteria for juvenile systemic lupus erythematosus: a cross sectional study. JIA, JSLE
51  2018 Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial. ANA, SLE, SMILE
52  2018 Systemic lupus erythematosus in a patient with Noonan syndrome-like disorder with loose anagen hair 1: More than a chance association. ACR, SLE
53  2018 The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination. a-dsDNA, ACR, dsDNA, SLE
54  2018 The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus. CSI, MMSE, MoCA, SLE
55  2018 The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus. ACR, CLE, SLE
56  2018 Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus. IL-22, IL-22BP, JSLE, LN
57  2018 Validation of the Systemic Lupus International Collaborating Clinics classification criteria in acohort of patients with full house glomerulardeposits. SLE
58  2017 Anti-C1q Antibody is Associated with Renal and Cutaneous Manifestations in Asian Indian Patients with Systemic Lupus Erythematosus. ACR, LN, SLE, SLEDAI
59  2017 Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: analysis of a large monocentric cohort with a long-term follow-up. ACR, aPL, SLE, UCTD
60  2017 Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis. ACR
61  2017 Cognitive dysfunction in patients with Systemic Lupus Erythematosus. ANA, MoCA, SLE
62  2017 Complement levels and risk of organ involvement in patients with systemic lupus erythematosus. ACR, dsDNA
63  2017 Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis. JSLE
64  2017 Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol. HRQoL, Mex-SLEDAI, SLE
65  2017 Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patientswith systemic lupus erythematosus. LLDAS, SLE
66  2017 Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria. SLE
67  2017 Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. ACR, JADI, JMCTD, PM, RF, SLE, SSc
68  2017 Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study. NN, NP, SLE
69  2017 Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE. ACR, APS, OPN, SDI
70  2017 Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus. cSLE, IDF, MetS, NCEP-ATP III, SD, WHO
71  2017 Ribosomal P antibody: 30 years on the road. SLE
72  2017 The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program. ACR, MLSP, SLE
73  2017 The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients. DFS70, OR
74  2017 Toward electronic health recording: evaluation of electronic patient reported outcome measures (e-PROMs) system for remote monitoring of early systemic lupus patients. ACR, e-PROMs, SLEDAI
75  2017 Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupus. ACR, ILE, SLEboth
76  2017 Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data System. ACR, ESRD, SLE
77  2016 An Unusual Case of Systemic Lupus Erythematosus and Hemophagocytic Syndrome. HLH, HS, SLE
78  2016 Association between academic performance and cognitive dysfunction in patients with juvenile systemic lupus erythematosus. ACR, JSLE, SLEDAI
79  2016 Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort. MI, SLE
80  2016 Clinical and financial burden of active lupus in Greece: a nationwide study. SLE, SLEDAI
81  2016 Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus. CVD, SLE
82  2016 Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort. cSLE, SLEDAI
83  2016 Expression of Toll‑like receptors3 and9 in Egyptian systemic lupus erythematosus patients. SLE, SLEDAI, TLR
84  2016 Is it primary neuropsychiatric systemic lupus erythematosus? Performance of existing attribution models using physician judgment as the gold standard. NPSLE
85  2016 Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years. ACR, cSLE, ESRD, LN
86  2016 Possible risk factors associated with greater damage in systemic lupus erythematosus patients: an Egyptian multicenter study. ACR, SLE
87  2016 Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature. SLE, TMA, TTP
88  2016 The effects of corticosteroids on cognitive flexibility and decision-making in women with lupus. ACR, SLE, SLEDAI
89  2016 The implication of tissue Doppler echocardiography and cardiopulmonary exercise in early detection of cardiac dysfunction in systemic lupus erythematosus patients. aCL, ACR, CPX, LV, PW, QOL, RV, SLAM, SLE, TAPSE, TDE
90  2016 Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE). ACR, SCLE, SLE
91  2016 Validation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus. AI, BILAG-R, ISN/RPS, NIH, SDI-R, SLEDAI-R, TIAI
92  2015 Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks. ACR, SLE
93  2015 Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register. ACR-97, CI, SLE
94  2015 Cardiac tamponade as the initial presentation of systemic lupus erythematosus: a case report and review of the literature. cSLE, SLE
95  2015 Characteristics of azathioprine use and cessation in a longitudinal lupus cohort. AZA, MMF, SLE
96  2015 Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort. ACR, SLE
97  2015 Diagnosis and risk stratification in patients with anti-RNP autoimmunity. CI, MCTD, OR, SLE
98  2015 Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort. QTd, SDI, SLE
99  2015 Embolic Stroke as the Initial Manifestation of Systemic Lupus Erythematosus. TEE
100  2015 Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. ACR, SDI, SLE